Gene · 5754
Papers1,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth. | Cancer Res | 2023 | 36622276 | PubTator, text mining | PubMed |
| The Research Advances of Aptamers in Hematologic Malignancies. | Cancers (Basel) | 2023 | 36612296 | PubTator, text mining | PubMed |
| SALL4-related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features. | Mol Oncol | 2023 | 36587397 | PubTator, text mining | PubMed |
| Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2. | EBioMedicine | 2023 | 36584595 | PubTator, text mining | PubMed |
| A Sarcomatoid Renal Cell Carcinoma with Clear Cell Papillary-Like Primary Tumor and Lymph Node Metastasis: A Diagnostic Conundrum. | Int J Surg Pathol | 2023 | 36562104 | PubTator, text mining | PubMed |
| A fluorescent probe for protein tyrosine kinase 7 detection in serum and cell imaging. | Talanta | 2023 | 36470013 | PubTator, text mining | PubMed |
| Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation. | J Proteome Res | 2023 | 36450103 | PubTator, text mining | PubMed |
| Resistance to antibody-drug conjugates in breast cancer: mechanisms and solutions. | Cancer Commun (Lond) | 2023 | 36357174 | PubTator, text mining | PubMed |
| XIAP and PHB1 Regulate Anoikis through Competitive Binding to TRAF6. | Mol Cancer Res | 2023 | 36346305 | PubTator, text mining | PubMed |
| Role of Long Intergenic Noncoding RNAs in Cancers with an Overview of MicroRNA Binding. | Mol Diagn Ther | 2023 | 36287372 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Protein Tyrosine Kinase 7 (PTK7) Promotes Metastasis in Hepatocellular Carcinoma via SOX9 Regulation and TGF-β Signaling. | Cell Mol Gastroenterol Hepatol | 2023 | 36202326 | PubTator, text mining | PubMed |
| Recent developments in biosensing methods for extracellular vesicle protein characterization. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | 35999185 | PubTator, text mining | PubMed |
| Loss of mitochondrial fatty acid β-oxidation protein short-chain Enoyl-CoA hydratase disrupts oxidative phosphorylation protein complex stability and function. | FEBS J | 2023 | 35962613 | PubTator, text mining | PubMed |
| Advances in metal graphitic nanocapsules for biomedicine. | Exploration (Beijing) | 2022 | 37324797 | PubTator, text mining | PubMed |
| CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. | Nat Aging | 2022 | 37118088 | PubTator, text mining | PubMed |
| Recent developments in isolating methods for exosomes. | Front Bioeng Biotechnol | 2022 | 36714629 | PubTator, text mining | PubMed |
| Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells. | Biomedicines | 2022 | 36672537 | PubTator, text mining | PubMed |
| A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer. | Front Pharmacol | 2022 | 36618922 | PubTator, text mining | PubMed |
| Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments. | Molecules | 2022 | 36615466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5754/papers?page=15